Mankind Pharma Limited
Indian Pharmaceutical Exporter ยท Advanced Antibiotics Specialist ยท $58.3M Total Trade ยท DGFT Verified
Mankind Pharma Limited is an Indian pharmaceutical exporter with a total trade value of $58.3M across 15 products in 10 therapeutic categories. Based on 1,614 verified export shipments from Indian Customs (DGFT) records, Mankind Pharma Limited is the #1 Indian exporter in 5 products including Nitrofurantoin, Phenylephrine, Tobramycin. Top exports include Nitrofurantoin ($11.1M), Formoterol ($8.6M), Phenylephrine ($7.0M).
Mankind Pharma Limited โ Export Portfolio & Destination Treemap

Who is Mankind Pharma Limited? โ Company Overview & Market Position
Mankind Pharma Limited, established in 1991, is a prominent Indian pharmaceutical and healthcare company headquartered in New Delhi. The company was founded by brothers Ramesh C. Juneja and Rajeev Juneja, who began operations with a seed capital of โน20,000 and a team of 20 employees. Over the years, Mankind Pharma has expanded its product portfolio to include pharmaceuticals, generic drugs, over-the-counter (OTC) products, fast-moving consumer goods (FMCG), and diagnostics.
As of 2023, Mankind Pharma operates 25 manufacturing facilities and 6 research and development centers across India. The company employs over 22,000 individuals, reflecting its significant presence in the pharmaceutical industry. In the fiscal year ending March 31, 2025, Mankind Pharma reported a revenue of โน10,335 crore, with domestic revenue accounting for โน9,522 crore. The company's registered office is located at 208, Okhla Industrial Estate, Phase-III, New Delhi, Delhi - 110020.